Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast Cancer
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Recent data have shown anterior gradient 2 (AGR2) to be a novel oncogene overexpressed in luminal breast cancers. However, many studies only focused on its relationship with treatment resistance, and the clinical relevance of AGR2 has not been widely evaluated.
著者Lacambra MD, Tsang JYS, Ni YB, Chan SK, Tan PH, Tse GM
期刊名稱Annals of Surgical Oncology
出版年份2015
月份10
日期1
卷號22
期次11
出版社SPRINGER
頁次3489 - 3496
國際標準期刊號1068-9265
電子國際標準期刊號1534-4681
語言英式英語
Web of Science 學科類別Oncology; Surgery

上次更新時間 2020-07-07 於 02:19